
VitriLife® Technology Overview
VitriLife® is the 1st scalable vitrification platform designed for the long-term ambient temperature stabilization of microbial and biological materials.
-
Designed as a more efficient, scalable, and cost-effective alternative to lyophilization resulting in superior stabilization for real world environments.
-
Immobilizes biological materials in a sugar glass matrix.
-
Arrests rotational and translational motion of molecules.
-
Achieves significant increases to product shelf life and improves activity yields.
-
Maintains higher titer after drying and subsequent storage.
-
Reduces logistical burden of cold chain, packaging, and shipping costs.
-
Enables micronization (milling foam to powder) without product damage.
-
Enables formulation of combination/multi-component products.
-
Instantaneous reconstitution at site of delivery.
-
The cornerstone of the VitriLife platform is our patented state-of-the-art drying by boiling process known as preservation by vaporization (PBV).

Expertise in the stabilization and delivery of a wide range of biologics such as:
-
Vaccines (e.g. mRNA, live viral and bacterial vaccines)
-
Therapeutic Proteins
-
Microbiome Therapeutics
-
Probiotics
-
Agricultural Biologicals (e.g. bacteria, fungi)
-
Enzymes
and much more...
How does VitriLife technology compare against other drying technologies?

VitriLife technology allows the scalable production of thermostable vaccines and other biologics in vials and/or in bulk format
